Your path in the tree: Start > Economics of Welfare > Health Economics > Economics of Pandemics > Preparation > Infrastructure and Research

Infrastructure and Research

Narrower topics in the RePEc Biblio tree


This RePEc Biblio topic is edited by Christian Zimmermann (pzi1). It was first published on 2021-02-22 15:55:27 and last updated on 2021-02-22 15:55:27.

Most relevant research

  1. Eva K. Lee & Chien-Hung Chen & Ferdinand Pietz & Bernard Benecke, 2009, "Modeling and Optimizing the Public-Health Infrastructure for Emergency Response," Interfaces, INFORMS, volume 39, issue 5, pages 476-490, October, DOI: 10.1287/inte.1090.0463.
  2. Stephen E. Chick & Hamed Mamani & David Simchi-Levi, 2008, "Supply Chain Coordination and Influenza Vaccination," Operations Research, INFORMS, volume 56, issue 6, pages 1493-1506, December, DOI: 10.1287/opre.1080.0527.
  3. Arusha Cooray & Krishna Chaitanya Vadlamannati & Indra de Soysa, 2020, "Do bigger health budgets cushion pandemics?: An empirical test of COVID-19 deaths across the world," WIDER Working Paper Series, World Institute for Development Economic Research (UNU-WIDER), number wp-2020-165.
  4. Natalia Fabra & Massimo Motta & Martin Peitz, 2020, "Preparing for the Next Crisis: How to Secure the Supply of Essential Goods and Services," CRC TR 224 Discussion Paper Series, University of Bonn and University of Mannheim, Germany, number crctr224_2020_210, Aug.
  5. Espinal, M. & Aldighieri, S. & St. John, R. & Becerra-Posada, F., 2016, "International health regulations, ebola, and emerging infectious diseases in Latin America and the Caribbean," American Journal of Public Health, American Public Health Association, volume 106, issue 2, pages 279-282, DOI: 10.2105/AJPH.2015.302969.
  6. Joseph T Wu & Gabriel M Leung & Marc Lipsitch & Ben S Cooper & Steven Riley, 2009, "Hedging against Antiviral Resistance during the Next Influenza Pandemic Using Small Stockpiles of an Alternative Chemotherapy," PLOS Medicine, Public Library of Science, volume 6, issue 5, pages 1-11, May, DOI: 10.1371/journal.pmed.1000085.
  7. Boon, Wouter P.C. & Moors, Ellen H.M. & Meijer, Albert J., 2014, "Exploring dynamics and strategies of niche protection," Research Policy, Elsevier, volume 43, issue 4, pages 792-803, DOI: 10.1016/j.respol.2014.01.005.
  8. Michael Kremer & Jonathan D. Levin & Christopher M. Snyder, 2020, "Designing Advance Market Commitments for New Vaccines," NBER Working Papers, National Bureau of Economic Research, Inc, number 28168, Dec.
  9. Wallace, Matthew L. & Ràfols, Ismael, 2018, "Institutional shaping of research priorities: A case study on avian influenza," Research Policy, Elsevier, volume 47, issue 10, pages 1975-1989, DOI: 10.1016/j.respol.2018.07.005.
  10. Arthur E. Attema & Anna K. Lugnér & Talitha L. Feenstra, 2010, "Investment in antiviral drugs: a real options approach," Health Economics, John Wiley & Sons, Ltd., volume 19, issue 10, pages 1240-1254, October, DOI: 10.1002/hec.1549.